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A Breast Tissue Protein Expression Profile
Volunteers, sample collection and processing Healthy parous and nulliparous women between 40 and 60 yr. of age were recruited for this study at the Dr. Susan Love Research foundation in Santa Monica, CA (Table 1) . Volunteer consent protocols for donating breast tissue by core needle biopsy and for the preservation of confidentiality (volunteer identities were not obtained) were reviewed and approved by both the Institutional Review Board of Texas Tech University Health Science Center in El Paso, TX and the Institutional Review Board of the Dr. Susan Love Research Foundation. Ultrasound guided breast tissue biopsies were obtained via core needle biopsy after application of local anesthetic. A small piece was fixed in formalin for histology and remaining tissue was snap frozen for further molecular analysis. Volunteers were divided into three groups: early parous (first fullterm pregnancy ≤ 25 yr.), late parous (first full-term pregnancy ≥ 35 yr.) and nulliparous (never undergone a full-term pregnancy). All samples were collected at least 5 years after the last full-term pregnancy in all parous women. Only volunteers with a history of regular menses who were not on any medications or oral contraceptives within the last six months prior to sample collection were admitted to the study. Women with liver disease, renal disease, or endocrine problems were not included in the study.
Global protein profiling
Tissue proteomes of early, late and nulliparous women were probed for the expression of various proteins using the PhosphoExplorer antibody array (Full Moon BioSystems). Briefly lysis beads and extraction buffer were added to ~20 mg of tissue, vortexed for an hour on ice, and centrifuged (14,000 rpm / 20 min). The resulting supernatant was incubated at -80°C for 4h followed by a second centrifugation step (14,000 rpm / 20 min). Clarified protein lysates were then applied to the antibody array, followed by fluorescence labeling with Cy3-streptavidin (GE Healthcare, Pittsburgh, PA, USA). Fluorescence intensity was measured using the Axon GenePix Array Scanner (Molecular Devices, Sunnyvale, CA, USA) and normalized to beta-actin expression levels for each array. Changes in protein expression were analyzed using GeneSpring software v. 12.5 (Agilent, Santa Clara, CA, USA).
Immunohistochemistry of human breast tissue
Individual proteins of interest were probed on formalin fixed, paraffin-embedded normal mammary tissue sections using standard immunohistochemistry techniques. Briefly, sections were deparaffinized and prepared by heat induced antigen retrieval with Trilogy (Cell Marque, Rocklin, CA, USA) at 90°C for 1 hr. The slides were washed with PBS and incubated 15 min with blocking buffer containing 1% FBS (Invitrogen, Grand Island, NY, USA) followed by PeroxFree blocking buffer for 5 min. Tissues were then incubated at 4°C overnight with IGFR2, P70S6K, or aurora kinase A (Abcam, CA, USA) antibodies as per manufacturer's recommendations. Slides were washed with PBS and overlaid with PolyScan HRP label (Cell Marque, Rocklin, CA, USA) for 30 min, washed again, and then overlaid with DAB chromogen (Cell Marque, Rocklin, CA, USA). Slides were incubated with DAB chromogen until proper color development was observed. Finally, 
Statistics
Significant differences in protein expression between samples were assessed using un-paired Student's t-test. Asymptotic p-value computation and multiple correction testing were carried out using the Benjamini-Hochberg procedure. Volcano plots and the Venn diagram were generated using a fold change cutoff of ≥ 1.3 to identify proteins differentially expressed in early parous versus late and nulliparous groups.
Results
One hundred thirty two healthy volunteers were recruited for this study ( raw data from each protein array was first normalized and subjected to a ±1.3 fold-change cutoff and a p-value cutoff of ≤0.05. Distinct differences in protein expression were observed for all three groups but there was a subset of proteins in late/nulliparous individuals that shared a common expression pattern distinct from that observed in early parous individuals ( Fig. 1A -C ). This particular protein expression profile is likely involved in early paritymediated protection against breast cancer (Fig. 1C) .
Early parity alters expression of proteins involved in cell cycle regulation, DNA damage responses and apoptosis
Several proteins involved in the regulation of cell cycle progression and apoptosis were notably altered by early parity ( Table 2 , Fig. 2A ). Late/nulliparous women appear to have lower levels of total aurora kinase A (Table 2 ). This suggests that protein activation occurs at similar rates between the three groups, but total protein may be less stable or is translated less efficiently in late/nulliparous women. We also observe an increase in inhibitory phosphorylation of survivin, a key component of the chromosomal passenger complex (CPC) in late/nulliparous women ( Table 2 , Fig. 2A ). In addition, the active form of cyclin B1 is highly up regulated in late/nulliparous women compared to early parous women, while cyclin E1 is down regulated in late/nulliparous women ( Table 2 , Fig. 2A ). Active SMC1 (structural maintenance of chromosomes) is up regulated in late/nulliparous women, while BRCA1, p53, and RAD52 levels are down regulated or unstable in late/nulliparous women compared to early parous women ( Table 2 , Fig. 2A ). Total BRCA1 levels are lower in late/ nulliparous women (Table 2) as is the ratio of total-to-phosphorylated protein ( Fig. 2A) . Early parity alters expression of proteins involved in cell proliferation/cell growth Indeed, we have evidence that breast tissue from late/nulliparous women may have a higher rate of cell proliferation compared to breast tissue from early parous women. Many positive regulators of cell proliferation appear to be highly up regulated or activated in late/nulliparous breast tissue including PI3K/AKT, ABL, ATF, EGFR, HER3, ER-alpha, SRC, ELK-1, Ezrin, MEK1, MER, GSK3A and Fos (Table 3 , Fig. 2B ). However, there are also a few key proteins associated with increased cell proliferation that are down regulated or whose activity is inhibited in late/nulliparous women (Table 3) . These include FAK, FYN, P70S6K and P90RSK. Not only are total FAK protein levels lower in late/nulliparous women, we also see up regulation of tyrosine 407 phosphorylation, which inhibits FAK function (Table  3) . We further observe an increase in inhibitory phosphorylation of FYN, a SRC family kinase (Table 3) . Total P70S6K and P90RSK protein levels are also lower in late/nulliparous women. Meanwhile, there is no difference in the ratio of active-to-total P90RSK in either group (Fig. 2B) . Therefore, this protein expression pattern is still consistent with increased cell proliferation in late/nulliparous individuals.
It is also noteworthy that the putative tumor suppressor, IGF2R (insulin-like growth factor 2), is decreased in late/nulliparous breast tissue (Table 3 ). We know from prior studies that IGF2R expression is associated with decreased IGF2 because IGF2R acts as a molecular sink to control IGF2 levels [26] . Additional studies indicate that IGF2R also regulates other growth factors through its ability to bind mannose-6-phosphate tagged proteins and its function as a shuttle from endosomes to lysosomes [27] . Thus increased IGF2R would be expected to decrease cell proliferation, while decreased levels of IGF2R would be expected to increase cell proliferation in response to various growth factors [26] .
Early parity alters expression of proteins involved in cell stress and inflammation
It is perhaps not surprising that late/nulliparous protein profiles also appear to be associated with increased cell stress and inflammation. If cell growth and proliferation are occurring at a higher rate than normal and this is in conjunction with increased genomic instability, then we can also expect higher levels of cellular stress and inflammation. A couple of proteins often activated by cellular stress are up regulated in late/nulliparous individuals compared to early parous individuals (Table 4) . These are ATF-1 (pSer63) and MAPKAPK-2 (pThr222). Another series of proteins with proinflammatory functions are also differentially expressed in late/nulliparous women including ICAM-1, NF-kB p65 (pSer529), IkB-beta (p-Thr19), IKK-beta (pTyr188), and STAT1 (pSer727) ( Table 4) . Several of these proteins also exhibit a clear trend for increased levels of active-to-total protein in late/nulliparous women (Fig. 2C) . In a neuroblastoma cell line, both growth factor stimulus and cellular stress activated MAPKAPK-2, which in turn activated CREB and ATF-1 [28] . Also in cortical neurons, activating transcription factor 1 (ATF-1) protects from oxidative stress-induced apoptosis through a hypoxia-inducible pathway involving HIF-1, ATF-1/CREB, p21, and EPO (erythropoietin) [29] . Thus, it is interesting that here we see concurrent up regulation of active MAPKAPK-2, ATF-1 and erythropoietin receptor in late/nulliparous women (Table  3 and 4) . It is intriguing to speculate that these proteins may play similar roles in breast epithelial cells where cell stress and/or growth factor stimulus would invoke this particular signaling pathway as a protective mechanism against oxidative and apoptotic stresses.
Further, the fact that ICAM-1 was significantly up regulated in breast tissue of late/ nulliparous women (Table 4 , Fig. 2C ) is an indication of enhanced inflammation. ICAM-1 is normally expressed at low levels on epithelial cells and other cell types, but is quickly up regulated by inflammatory stimuli [30] . Moreover, ICAM-1 expression is up regulated in epithelial tissue from early, late and nulliparous individuals. For this analysis, IGF2R, P70S6K, and aurora kinase A were chosen based on functional and/or statistical relevance to the study. IHC staining of mammary epithelial cells revealed that each of these proteins follows the same expression pattern as that observed in our protein array results (Fig. 4 , Table 2 and 3). In agreement with the protein array results, these proteins are expressed at much higher levels in early parous breast epithelial cells compared to late/nulliparous breast epithelial cells (Fig. 4) . Thus, the data from our protein array analysis appears to be accurate and reproducible. Moreover, it is significant that these protein expression patterns were faithfully reproduced specifically in breast epithelial cells (Fig. 4) .
Discussion
The purpose of this study was to identify a protein expression signature unique to early parous women that may be useful in predicting the risk of breast cancer development 
and progression in a diverse population of women. To our knowledge, this is the first largescale study to assess global parity-induced changes at the protein level in normal human breast tissue. It is also our understanding that this is the first study to assess parity-related changes in normal human breast tissue stratified according to early and late parity, as well as, nulliparity. Many prior studies have assessed changes at the transcript level in parous versus nulliparous populations [4, 19, 21, 22] . The study design we have implemented here is critical for assessing changes in the mammary gland that truly play a role in parity-related breast cancer protection. There are many parity-related changes in breast tissue that may not play a role in protection against breast cancer or may even play an adverse role in breast cancer risk. In order to distinguish these effects from the true protective effects of parity we have compared protein expression changes in early parous women (low risk group) with protein expression changes commonly shared by both late and nulliparous women (high risk groups). Using this strategy, we successfully identified a protein expression signature unique to early parous women that is distinct from both late and nulliparous women. This unique protein expression signature indicates that late/nulliparous breast tissue may suffer increased cell proliferation and stress, as well as, increased genomic instability and inflammation. These observations are in line with previous gene expression studies in both humans and rodents where the genomic profile of parous mammary tissue suggests a more mature and less proliferative state compared to non-parous counterparts [4, 19, 21, 22] . Indeed, a recent study reported increased levels of Her2 (epidermal growth factor receptor 2) and Esr1 mRNA in nulliparous versus early breast tissue [21] . Although we did not observe increased HER2 protein in this study, we did observe increased levels of two other proteins in the same family-EGFR (HER1) and HER3-in late/nulliparous individuals. Further, we also observed increased levels of ESR1 protein in late/nulliparous vs. early parous women. Thus, it appears that early parity represses human epidermal growth factor and estrogen signaling at both the transcript level [21] and the protein level-two key changes that likely contribute to reduced breast cancer risk in early parous women [4] . In line with increased growth factor and steroid hormone signaling in late/nulliparous women, we also found up regulation of several growth-promoting signaling networks in late/nulliparous breast tissue. These include PI3K/AKT, ATF, FOS and SRC signaling networks.
The concept that a higher degree of cell division can act as a "cancer promoter" for certain types of cancers surfaced in the late 1980's based on epidemiologic evidence [33] . Genotoxic agents such as ionizing radiation or tobacco can by themselves directly cause genetic mutations that may result in malignant transformation. On the other hand, the constant DNA damage rate of a given cell and the resulting amount of irreparable DNA damage can be considered a direct function of that cell's rate of division over time [33] . Thus, any agent or circumstance that enhances cell division would also be expected to promote malignant transformation over an extended period of time. This hypothesis is consistent with breast cancer etiology since hormone dependent breast cancers tend to develop much later in life and account for two thirds of all breast cancer cases [33] . Furthermore, genotoxic insult would be expected to have the most profound effect in a rapidly dividing cell population as opposed to a cell population where proliferation is much lower or even nonexistent, as in the case of Schwann cells which rarely divide and do not form cancers [33] . Therefore, whether increased rates of cell proliferation act alone or in concert with genotoxic insult, we can conclude that higher rates of cell division can significantly increase the risk of breast cancer in late/nulliparous populations.
In agreement with this, we also find evidence of increased genomic instability in late/ nulliparous breast tissue. Aurora kinases A, B, and C are cell cycle proteins essential for appropriate chromosome alignment and segregation during cell division [34] . AurA (aurora kinase A) is required for microtubule formation/stabilization at the spindle pole to facilitate appropriate chromosome segregation during mitosis. Insufficient expression of AurA is associated with mitotic abnormalities that culminate in cytokinesis failure and polyploidy [34] . In particular, problems arise when aberrant expression of aurora kinases is accompanied by p53 deficiency as this can lead to aneuploidy or polyploidy [34] . Here, we have evidence that [34] . Given these observations, it is of particular concern that active cyclin B1 is up regulated in late/nulliparous women because cyclin B1 is essential for pushing the cells through mitosis. Cyclin E1 is expressed at lower levels, suggesting that there may be greater control at the S-phase of the cell cycle in late/nulliparous women. However, faster progression through mitosis is still of great concern as this is the final step in cell division. Therefore, combined p53/BRCA1/RAD52/aurora kinase deficiency and faster progression through mitosis may work together to increase genomic instability in late/nulliparous women. This would increase the chances of malignant transformation. Therefore, an important issue to address in future research is to determine the molecular events responsible for decreased levels/ activity of these critical DNA-damage repair pathways. If these cells are indeed subject to a much greater level of genomic instability, it is likely that this is directly connected to the increased expression of proteins associated with greater cell stress and inflammation in late/nulliparous breast tissue. In summary, we have shown that early parity is characterized by more efficient expression/activation of breast tumor suppressors p53, RAD52, and BRCA1. In addition, early parity significantly down regulates mitogenic EGFR, ESR1, and other pro-survival signaling pathways. Early parity may also be associated with less cellular stress and dampened inflammatory responses in the breast. This unique protein expression signature further expands our knowledge of how early parity may protect against breast cancer and will be invaluable for identification of breast cancer biomarkers and for development of superior breast cancer prevention/treatment strategies.
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